前收市價 | 2.5100 |
開市 | 2.5500 |
買盤 | 1.0500 |
賣出價 | 1.1500 |
拍板 | 65.00 |
到期日 | 2024-11-15 |
今日波幅 | 2.5100 - 2.5500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 78 |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.